Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant.
about
Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threatTriplet nucleotide removal at random positions in a target gene: the tolerance of TEM-1 beta-lactamase to an amino acid deletion.Escherichia coli β-Lactamases: What Really MattersCrystal Structure of a Preacylation Complex of the β-Lactamase Inhibitor Sulbactam Bound to a Sulfenamide Bond-Containing Thiol-β-lactamaseDesign and Exploration of Novel Boronic Acid Inhibitors Reveals Important Interactions with a Clavulanic Acid-Resistant Sulfhydryl-Variable (SHV) β-LactamaseCan Inhibitor-Resistant Substitutions in the Mycobacterium tuberculosis -Lactamase BlaC Lead to Clavulanate Resistance?: a Biochemical Rationale for the Use of -Lactam- -Lactamase Inhibitor CombinationsNosocomial outbreak of Klebsiella pneumoniae producing SHV-5 extended-spectrum beta-lactamase, originating from a contaminated ultrasonography coupling gel.Discriminatory detection of inhibitor-resistant beta-lactamases in Escherichia coli by single-strand conformation polymorphism-PCR.Selection and characterization of beta-lactam-beta-lactamase inactivator-resistant mutants following PCR mutagenesis of the TEM-1 beta-lactamase geneCharacterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods.Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens.Molecular characterization of TEM-59 (IRT-17), a novel inhibitor-resistant TEM-derived beta-lactamase in a clinical isolate of Klebsiella oxytocaA novel complex mutant beta-lactamase, TEM-68, identified in a Klebsiella pneumoniae isolate from an outbreak of extended-spectrum beta-lactamase-producing Klebsiellae.Rapid discriminatory detection of genes coding for SHV beta-lactamases by ligase chain reaction.TEM-109 (CMT-5), a natural complex mutant of TEM-1 beta-lactamase combining the amino acid substitutions of TEM-6 and TEM-33 (IRT-5).CMT-type beta-lactamase TEM-125, an emerging problem for extended-spectrum beta-lactamase detection.Characterization of the inhibitor-resistant SHV β-lactamase SHV-107 in a clinical Klebsiella pneumoniae strain coproducing GES-7 enzyme.Multiplex asymmetric PCR-based oligonucleotide microarray for detection of drug resistance genes containing single mutations in Enterobacteriaceae.The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.Prevalence and Molecular Characterization of Plasmid-mediated Extended-Spectrum β-Lactamase Genes (balaTEM, blaCTX and blASHV) Among Urinary Escherichia coli Clinical Isolates in Mashhad, Iran.Molecular and biochemical characterization of SHV-56, a novel inhibitor-resistant beta-lactamase from Klebsiella pneumoniae.Detection of resistance to beta-lactamase inhibitors in strains with CTX-M beta-lactamases: a multicenter external proficiency study using a well-defined collection of Escherichia coli strains.TEM-121, a novel complex mutant of TEM-type beta-lactamase from Enterobacter aerogenes.In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?Automated thermal cycling is superior to traditional methods for nucleotide sequencing of bla(SHV) genes.TEM-89 beta-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3Inhibitor-resistant OXY-2-derived beta-lactamase produced by Klebsiella oxytoca.Properties of mutant SHV-5 beta-lactamases constructed by substitution of isoleucine or valine for methionine at position 69.Mutant TEM beta-lactamase producing resistance to ceftazidime, ampicillins, and beta-lactamase inhibitors.Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant beta-lactamases at a University Hospital in Barcelona, Spain, over a 3-year periodHaemophilus influenzae bla(ROB-1) mutations in hypermutagenic deltaampC Escherichia coli conferring resistance to cefotaxime and beta-lactamase inhibitors and increased susceptibility to cefaclorSHV-49, a novel inhibitor-resistant beta-lactamase in a clinical isolate of Klebsiella pneumoniae.Catalytic properties of class A beta-lactamases: efficiency and diversity.BetalasEN: microdilution panel for identifying beta-lactamases present in isolates of Enterobacteriaceae.Substitutions at position 105 in SHV family β-lactamases decrease catalytic efficiency and cause inhibitor resistance.Kinetic analysis of an inhibitor-resistant variant of the OHIO-1 beta-lactamase, an SHV-family class A enzymeBiochemical study of a new inhibitor-resistant beta-lactamase, SHV-84, produced by a clinical Escherichia coli strain.Effects of Ser130Gly and Asp240Lys substitutions in extended-spectrum beta-lactamase CTX-M-9.Genetic and Functional Characterization of blaCTX-M-199, a Novel Tazobactam and Sulbactam Resistance-Encoding Gene Located in a Conjugative mcr-1-Bearing IncI2 Plasmid.
P2860
Q24550671-083EFCAE-9ABA-45A3-A373-AB213C2B0E39Q24804616-168F2630-4182-4891-9D06-4A830B84A975Q26749590-13211431-AE59-4C75-B88A-25BF73C954B9Q27673054-C37B003B-6A81-4A67-B67B-013A34B90358Q27675536-8B76FE0B-22BD-4F1E-BF15-34A60A7AF247Q27680025-C64C8CAD-8D73-496D-BAF3-CC78E2004D14Q33666596-D1EB7C73-3C7A-412C-B7AD-6DF1892E720DQ33692735-D04DD3ED-3D73-4E2F-A123-63F1328B1981Q33693837-ACE48C89-2C74-4D8E-B54F-852845B6DE31Q33973139-8DBF0F5F-77B1-4382-BD56-2CE0E0C54DF6Q33976916-D804F0CF-DE21-400F-A477-79AAFEAECC46Q33977130-D61DE9D0-1E5E-40F4-9650-9E9B4860AD27Q33979670-9BEF4AB7-0822-4081-9A26-B43568182344Q33980007-821FF479-1F97-49F6-B413-A2CAC6679BE8Q34123641-3C366E91-242C-4816-A1AE-23EBB5CFEA31Q34721603-BC3CF3B8-5A66-4E55-B254-166F99C53F8FQ35689323-80672CA9-2BDB-45E4-A44F-01C1F78B4F8CQ36095002-EF05B372-A9CF-4D26-A64B-0BB8F76F2BEDQ36593875-D387BB3D-C218-4056-9DB7-460143C33E93Q36652600-6E2CD3E3-BB73-4DAD-B214-54F30873ECA0Q36932948-B65A337B-928F-409A-962E-058310C196D9Q37546694-0ABAFA0F-9506-44E7-A72A-0207FF12A2F6Q37624693-BDB880FB-2429-4437-93F3-433A152AFD22Q38626867-D4F10D2B-9A91-42F2-8992-0852A429481CQ39472406-713FF053-729E-45FC-A122-694516787D04Q39479247-A5896C7B-3B42-45B7-A2DA-C3640E38CC93Q39558506-37134D70-7F3A-4B27-83DA-0AEF1026B669Q39558648-98EC3737-9F48-42BE-BE5E-7FCC5B531332Q39652959-4866242F-5A71-441C-9650-C7BBAD943A87Q39671146-EB35138B-652E-4B5E-A6FF-934BCA12CA0CQ39792503-E695D413-7C64-4F85-92CC-635347BE06C2Q40289276-44872A43-590A-4B58-AB3C-672EBF0C281FQ40863105-F8E93D5F-B465-4D99-A992-07BF22C816BFQ41142049-0074A8E4-7AA5-4986-BEAD-EB8DEEB5E27EQ41571099-B335BEA6-4436-4F9E-9DDF-66FC3F0E4A0AQ41882000-DA46E214-4AA3-4C40-98A6-A0C680BC837FQ42794452-E401C744-5A98-4A1D-89D7-99B227493F78Q42925117-7C9A0C2E-C47B-40BF-8825-4D2C6B2CCDC0Q49701622-F91C6934-8B7E-4145-9C5B-54830885EF00
P2860
Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Emergence of an inhibitor-resi ...... derived from an SHV-5 variant.
@en
Emergence of an inhibitor-resistant beta-lactamase
@nl
type
label
Emergence of an inhibitor-resi ...... derived from an SHV-5 variant.
@en
Emergence of an inhibitor-resistant beta-lactamase
@nl
prefLabel
Emergence of an inhibitor-resi ...... derived from an SHV-5 variant.
@en
Emergence of an inhibitor-resistant beta-lactamase
@nl
P2093
P2860
P356
P1476
Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant
@en
P2093
Miriagou V
Prinarakis EE
Tzouvelekis LS
P2860
P304
P356
10.1128/AAC.41.4.838
P407
P577
1997-04-01T00:00:00Z